The FFL crew expains which players could ball out in 2021.
The FFL crew expains which players could ball out in 2021.
Dr Oluwajoba Oroge braced for the week ahead - another long line of coronavirus patients at Abuja's EHA clinic, and another long wait for news of a vaccine. More than 2,600 Nigerian physicians have contracted COVID-19 and dozens of them have died, said Dr Adetunji Adenekan, chairman of the Lagos state branch of the Nigerian Medical Association. Nigeria's health minister Osagie Ehanire said last month he was hoping to see the fist vaccines arrive through the global COVAX scheme in January, though he gave no details on precise timing, or which shot Nigeria would get.
Too many on the left and right agree that the government can use economic leverage to curb our rights.
In the midst of historic and painful political, public health, economic and racial crises, Americans of all ages are seeking the Truth and wisdom they need to guide their choices and ensure their continued freedom and wellbeing. To expand their understanding of how the human Conscience can be optimized to solve all of life's challenges, Leonard Perlmutter, founder of the American Meditation Institute(AMI) and National Conscience Month, will teach two special six-week workshops entitled the Foundation Course of Yoga Science beginning on Saturday afternoons February 13 and Wednesday evenings March 3, 2021.
The "North America Fiber Optic Gyroscope Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Sensing Axis, Device, and Application" report has been added to ResearchAndMarkets.com's offering.
B2Broker has added a new range of features to its B2Trader Matching Engine, delivering the ultimate in performance and functionality.
Mostly Serious, a full-service digital marketing agency specializing in custom web design, digital marketing, SEO, and content, has named a new president, CEO, and creative director. Each role was filled by individuals already employed by Mostly Serious.
The CBD industry is still in its infancy, so educating consumers is key to ensuring its continued growth and success. At Real Tested CBD, the fact that not all CBD is created equal is realized and reviewed, giving consumers an equal opportunity at making an informed purchase that is worth the price.
Mellitox is one of the most powerful supplements available in the market to control and balance blood sugar levels in the blood. It's an up-and-coming supplement which has proved to be extremely effective. As per the manufacturers, it's a clinically tested product with naturally occurring herbs. So, the supplement won't harm the user if they take its regular dose.
Cue Health Inc. (Cue) announced today that its molecular, point-of-care COVID-19 Tests are being distributed to five additional states, including Colorado, Minnesota, Pennsylvania, Rhode Island and Utah, as part of the joint $481 million program with the U.S. Department of Health and Human Services (HHS) and the Department of Defense (DOD). This expansion doubles the number of states participating in the program. Cue expects to deliver six million tests by the spring. Cue's COVID-19 Tests are being used in point-of-care settings to provide molecular confirmation to antigen tests that yield positive and suspicious negative results, eliminating the need to send results to a central lab and thereby enabling healthcare providers to respond immediately.
UCLOUDLINK GROUP INC. (NASDAQ: UCL, "uCloudlink"), the world's first and leading mobile data traffic sharing marketplace, has inked a Strategic Cooperation Framework Agreement with China Vehicle Interconnected Transport Capacity Technology Co., Ltd. ("CVITC"), a container transportation and logistics company in China. The partnership will see both companies develop innovative smart container solutions for domestic and international freight markets powered by uCloudlink's core patented Cloud SIM technology which accelerates the development of the global container transportation industry.
FirstService Residential, Nevada's leading community management company, was awarded the contract to provide full-service management services for Silverstone Ranch Community Association, a master-planned community in Las Vegas, Nevada. FirstService Residential assumed management responsibilities on January 1, 2021.
Maybe Jill Biden can fix it.
The "Global GIS Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
Dublin, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The "Supportive Care in Cancer - Comprehensive Overview, Pipeline Products, Research and Development Strategies and Unmet Needs" report has been added to ResearchAndMarkets.com's offering. The report leverages on survey-based data and KOL insights to provide a comprehensive overview on a number of aspects including current treatment options that are used for various indications within SCC and treatment guidelines that are observed for these indications. In terms of clinical development, pipeline products and R&D strategies for individual indications are addressed. The report also delves into some of the clinical trials challenges that are encountered in this field and provides an overview of unmet needs that exist for various SCC indications.Supportive care in cancer is an evolving discipline of medicine that is critical for holistic management of patients with cancer. With significant advancements being made in treatment of cancer particularly through development of immuno-oncology (IO) and targeted therapies, it is of equal significance to focus on supportive care in cancer so as to ensure that patients are able to complete the treatment cycle for the primary cancer as well as to enhance their quality of life.Key Highlights Advancements in understanding of disease mechanisms coupled along with therapeutic advancements in some of the SCC indications are expected to increase awareness of this field.Although significant therapeutic advancements have been made for some SCC indications, analysis of the overall field indicate that there is disparity in terms of current treatment options, particularly for indications in which approved therapies are non-existent.Breadth of pipeline products in clinical development holds promise for SCC particularly for indications that are currently under-served in terms of approved therapies.Existence of both clinical and environmental unmet needs within SCC field provide an opportunity for pharmaceutical companies and policy makers to help develop effective therapeutics and frameworks respectively, to advance the field further. Therapies that can offer a significant benefit to patients particularly in terms of improving quality of life and frameworks from regulatory agencies that can facilitate guidance, specifically on some SCC indications are of particular importance to help address the existing gap. Key Questions Answered What set of treatment guidelines and treatment options are used by oncologists in the 7MM for various indications within SCC?What is the current status of SCC particularly with regards to physician attitude and how is this trend likely to change in the future? What sort of impacts are newer agents such as those related to IO and targeted therapies having on the SCC field?What are the different R&D strategies that are being pursued by pharmaceutical companies within individual indications under SCC? What are the challenges associated with clinical trials in this field?What are the current unmet needs, and what steps are being taken to help address these gaps in SCC? Key Topics Covered: 1. Preface2. Executive Summary2.1. Key Findings3. Supportive Care in Cancer Overview3.1. What is Supportive Care in Cancer?4. Epidemiology4.1. Diagnosed Incident Cases of All Cancer in 20194.2. Diagnosed Incident Cases of All Cancer Receiving Chemotherapy4.3. Diagnosed Incident Cases of All Cancer Receiving Chemotherapy with Condition4.4. Five-Year Diagnosed Prevalent Cases of All Cancer5. Current and Future Status of Treatment Guidelines5.1. Treatment Guidelines for Various Indications Within Supportive Care in Cancer - Survey Results5.2. Reasons for Non-Adherence to Treatment Guidelines - KOL Opinion5.3. Commonly Used Treatment Guidelines for Indications Within Supportive Care in Cancer5.4. Current Status of Supportive Care in Cancer - KOL Opinion5.5. Physician Attitude Towards Supportive Care in Cancer - KOL Opinion5.6. Future Outlook for Supportive Care in Cancer - KOL Opinion5.7. Impact of Immuno-Oncology Therapies and Targeted Therapies on SCC - KOL Opinion5.8. Role of Immuno-Oncology Therapies and Targeted Therapies on Producing New Side Effect Profiles - KOL Opinion6. Current Treatment Options6.1. Key MOAs for Various Indications Within Supportive Care in Cancer6.2. Key Marketed Product Information for Various Indications Within Supportive Care in Cancer6.3. Commonly Used Marketed Products for Various Indications Within Supportive Care in Cancer - Survey Results6.4. Level of Satisfaction With Marketed Products for Various Indications Within Supportive Care in Cancer - SurveyResults6.5. Marketed Products for Various Indications Within Supportive Care in Cancer - KOL Perspective7. Pipeline Products and R&D Strategies7.1. Level of Familiarity and Potential for R&D Strategies for Various Indications Within Supportive Care in Cancer -Survey Results7.2. Pipeline Products for Various Indications Within Supportive Care in Cancer - KOL Opinion8. Clinical Trial Design and Challenges8.1. Clinical Trials Challenges and Endpoints for Various Indications Within Supportive Care in Cancer - Survey Results8.2. Clinical Trials Challenges and Endpoints for Various Indications Within Supportive Care in Cancer - KOL Opinion9. Unmet Needs and Opportunities9.1. Major Unmet Needs for Various Indications Within Supportive Care in Cancer9.2. Level of Significance of Unmet Needs for Various Indications Within Supportive Care in Cancer - Survey Results9.3. Unmet Needs for Various Indications Within Supportive Care in Cancer - KOL Opinion10. Appendix Companies Mentioned AbbVieAliud PharmaAmgenAsahi Kasei Pharma CorpAstraZenecaBayer HealthcareBenuvia TherapeuticsBetterLife PharmaBeyondSpringBristol-Myers SquibbChugai PharmaceuticalDaichii SankyoDauntless Pharmaceuticals IncHelsinn GroupHeron TherapeuticsImmune PharmaceuticalsJanssen-CilagKyowa KirinLTL PharmaMedice Arzneimittel PutterMediciNovaMerckMirati TherapeuticsMundipharma International LtdMylan PharmaceuticalsNapo PharmaceuticalsNovartisOno PharmaceuticalPartner TherapeuticsPfizerPHD BiosciencesQ BioMedRatiopharmRelypsaRocheRottapharmSandozSobiSpectrum PharmaceuticalsStada ArzneimittelTaiho Pharmaceutical Co LtdTerSera TherapeuticsTeva PharmaceuticalsTorii PharmaceuticalWEX Pharmaceuticals Inc For more information about this report visit https://www.researchandmarkets.com/r/ujtjev Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Google is writing check to another startup in India. The Android-maker, which last year unveiled a $10 billion fund to invest in the world's second largest internet market, said on Tuesday that it is participating in a $40 million investment round of hyperlocal delivery startup Dunzo, a Bangalore-based firm that it has also previously backed. Five-year-old Dunzo said Google, Lightbox, Evolvence, Hana Financial Investment, LGT Lightstone Aspada, and Alteria among others participated in its Series E financing round, which brings its to-date raise to $121 million.
North Korea's trade with China plunged more than 80% last year, Chinese customs data has shown, as the isolated country's strict coronavirus lockdown encumbers an economy already burdened by international sanctions. China is North Korea's top ally and accounts for some 90% of its trade volumes. Two-way trade plummeted nearly 80.7% to $539 million last year from 2019, Chinese customs data released on Monday showed.
The 24-year-old son of Stephanie Seymour and Peter Brant died from an accidental overdose, his family have said.
during the forecast period. Growth in the market can primarily be attributed to factors such as stringent regulations in the pharmaceutical industry, growing food safety concerns, increasing government in Infrared technologies and technological advancements in the market.New York, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Infrared & Terahertz Spectroscopy Market by Instrument Type, Spectrum, Application - Global Forecast to 2025" - https://www.reportlinker.com/p03711133/?utm_source=GNW The terahertz spectroscopy market is expected to reach USD 45 million by 2025 from USD 30 million in 2020, at a CAGR of 8.3% during the forecast period. Growth in the market can primarily be attributed to factors such as increasing applications of terahertz spectroscopy as a screening technique in homeland security, the growing semiconductor industry, and technological advancements.The benchtop segment to hold the largest market share in 2020.Based on instrument type, the infrared spectroscopy market is segmented into benchtop instruments, portable instruments, microscopy instruments and hyphenated instruments. In 2020, the benchtop instruments segment is expected to command the largest share of the infrared spectroscopy market. The large share of this segment can be attributed to the advantages offered by benchtop instruments such as improved workflow, minimum space requirements, and fewer maintenance requirementsThe pharmaceutical and biotechnology applications segment to hold the largest market share in 2020.Based on the applications, the infrared spectroscopy market is segmented into food & beverage testing, pharmaceutical & biotechnology applications, industrial chemistry applications, environmental testing, and other applications (academic applications, forensic applications, biomonitoring, and agricultural applications).In 2020, the pharmaceutical and biotechnology applications segment to command the largest share of the infrared spectroscopy market.The large share of this segment can be attributed to the stringent regulations in the pharmaceutical industry.The mid-infrared radiation segment to hold the largest market share in 2020.Based on spectrum, the infrared spectroscopy market is segmented into mid-infrared radiation, near-infrared radiation and far-infrared radiation.In 2020, the mid-infrared radiation segment is expected to command the largest share of the infrared spectroscopy market.The increase in the number of healthcare and pharmaceuticals applications and extensive usage in the food industry are driving the growth of this segment.The semiconductor segment to hold the largest market share in 2020.Based on application, the terahertz spectroscopy market is segmented into semiconductor, homeland security, non-destructive testing and research & development.In 2020, the semiconductor segment is expected to command the largest share of the terahertz spectroscopy market.Technologicala dvancements in the growing semiconductor industry is the major factor riving the growth of this segment.The Asia Pacific region to witness the highest growth during the forecast period.Geographically, North America dominated the global infrared & terahertz spectroscopy market in 2020.However, the Asia Pacific market is expected to register the highest during the forecast period.The major factors driving the growth of the Asia Pacific market include strategic expansions by key players, increasing food safety concerns and adoption of technologically advanced products.Break of primary participants was as mentioned below:• By Company Type: Tier I: 43%, Tier II: 33%, Tier III: 24%• By Designation: C-Level Executives: 37%, Directors: 40%, Others: 23%• By Region: North America: 30%, Europe: 25%, Asia Pacific : 28%, RoW: 17%PerkinElmer (US), Bruker Corporation (US) Shimadzu Corporation (US), Thermo Fisher Scientiific (US) were the leading players in the infrared spectroscopy market.TeraView Ltd (UK), Advantest Corporation (Japan), Menlo Systems GmbH (Germany) were the leading players in the terahertz spectroscopy market.Research CoverageThis report studies the infrared & terahertz spectroscopy market based on instrument type, spectrum, application and region.The report also studies the different factors (such as drivers, restraints, and opportunities) affecting the market growth.It provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.Key Benefits of Buying the ReportThis report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the infrared & terahertz spectroscopy market and their drivers, restraints, and opportunities. The report also provides impact of Covid-19 on the infrared & terahertz spectroscopy market and will help both established firms as well as new entrants/smaller firms to gauge the pulse of the infrared & terahertz spectroscopy market and garner greater market shares.Read the full report: https://www.reportlinker.com/p03711133/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
‘Substantial variation’ in antibody positivity between different regions of England, says Office for National Statistics
Follow all the latest developments